ATGE — Adtalem Global Education Inc.

Summary of Adtalem Global Education Inc. Q2 2026 Earnings Call

1. Key Financial Results and Metrics

• Revenue: Increased by 12.4% to $503.4 million, with a notable contribution from Walden due to a one-week academic calendar shift.
• Adjusted EBITDA: Rose by 23.9% to $154.9 million, with an adjusted EBITDA margin of 30.8%, expanding 290 basis points year-over-year.
• Adjusted Earnings Per Share (EPS): Increased by 34.3% to $2.43.
• Share Repurchases: $165 million deployed in share buybacks; $728 million remains under the current authorization.

2. Strategic Updates and Business Highlights

• Enrollment Growth: Achieved tenth consecutive quarter of enrollment growth, totaling 97,000 students, up over 6% year-over-year.
• Segment Performance:
  • Walden: Revenue increased by 27% to $217.6 million, with enrollment up 13%.
  • Chamberlain: Revenue grew by 1.6% to $183.8 million, but total enrollment declined by 1%. Positive trends in application volumes noted.
  • Medical and Veterinary Segment: Revenue rose by 6.9% to $102 million, with adjusted EBITDA increasing by 17.6%.
• Strategic Focus: Continued emphasis on addressing healthcare workforce shortages through capacity expansion and innovative learning solutions.

3. Forward Guidance and Outlook

• Revenue Guidance: Maintained for FY 2026 at $1.9 to $1.94 billion, reflecting 6% to 8.5% growth.
• Adjusted EPS Guidance: Raised to a range of $7.80 to $8.00, indicating growth of 17% to 20%.
• Enrollment Expectations: Anticipated recovery in Chamberlain's enrollment in the fall cycle, with potential for improved performance in the medical and veterinary segments.

4. Challenges and Points of Concern

• Chamberlain Enrollment: A temporary decline in total enrollment is expected, with concerns about the impact of recent marketing effectiveness and enrollment funnel conversion issues.
• Regulatory Risks: Potential changes in loan caps could affect student financing options, with ongoing developments in partnership with Sallie Mae for supplemental lending.
• Market Competition: The need to maintain competitive positioning in a challenging educational landscape, particularly in nursing and healthcare programs.

5. Notable Q&A Insights

• Walden's Growth: Continued strong performance attributed to robust enrollment in behavioral sciences and nursing programs, with expectations of market share gains.
• Chamberlain's Recovery: Management expressed confidence in addressing enrollment challenges through improved application volumes and marketing strategies, particularly as they approach the fall enrollment cycle.
• Regulatory Developments: Ongoing work with Sallie Mae to finalize a partnership aimed at enhancing student financing options, crucial for maintaining enrollment levels.

Overall, Adtalem Global Education Inc. reported solid financial performance in Q2 2026, with strategic initiatives aimed at addressing healthcare workforce shortages and enhancing enrollment growth, while also navigating challenges in specific segments and regulatory landscapes.